Coldstream Capital Management Inc. Sells 307 Shares of Integer Holdings Co. (NYSE:ITGR)

Coldstream Capital Management Inc. decreased its position in Integer Holdings Co. (NYSE:ITGR) by 14.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,790 shares of the medical equipment provider’s stock after selling 307 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Integer were worth $237,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. KBC Group NV increased its stake in shares of Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock worth $212,000 after acquiring an additional 726 shares in the last quarter. Versant Capital Management Inc boosted its position in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares in the last quarter. Tributary Capital Management LLC boosted its position in shares of Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock worth $38,103,000 after purchasing an additional 2,289 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Integer by 3.9% in the 4th quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider’s stock worth $24,154,000 after buying an additional 6,905 shares during the last quarter. Finally, Laurus Investment Counsel Inc. bought a new position in Integer during the 4th quarter valued at approximately $5,422,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

ITGR stock opened at $125.64 on Friday. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The company has a market cap of $4.38 billion, a P/E ratio of 37.39, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock’s fifty day moving average price is $118.84 and its 200-day moving average price is $130.10.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. During the same period in the previous year, the business posted $1.14 earnings per share. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. On average, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ITGR shares. Benchmark cut their target price on Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. StockNews.com lowered shares of Integer from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a “buy” rating in a research note on Friday, April 25th. KeyCorp reduced their price target on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Finally, Raymond James upped their price objective on Integer from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Integer has a consensus rating of “Moderate Buy” and an average price target of $145.56.

Insider Buying and Selling

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.16% of the stock is owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.